These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12147799)

  • 1. C2 (2-h) levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal-transplant patients.
    Jørgensen K; Povlsen J; Madsen S; Madsen M; Hansen H; Pedersen A; Heinsvig EM; Poulsen J
    Nephrol Dial Transplant; 2002 Aug; 17(8):1487-90. PubMed ID: 12147799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of tacrolimus in adult renal transplant recipients.
    Naik P; Madhavarapu M; Mayur P; Nayak KS; Sritharan V
    Drug Metabol Drug Interact; 2012; 27(3):151-5. PubMed ID: 23089531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients.
    Chen YH; Zheng KL; Chen LZ; Dai YP; Fei JG; Qiu J; Li J
    Transplant Proc; 2005 Dec; 37(10):4246-50. PubMed ID: 16387090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-hour blood tacrolimus levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal transplant patients.
    Jørgensen KA; Povlsen JV; Madsen S; Madsen M; Hansen HE; Pedersen AR; Heinsvig EM; Poulsen JH
    Transplant Proc; 2002 Aug; 34(5):1721-2. PubMed ID: 12176551
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
    Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus monitoring by simplified sparse sampling under the concentration time curve.
    Balbontin FG; Kiberd B; Squires J; Singh D; Fraser A; Belitsky P; Lawen J
    Transplant Proc; 2003 Nov; 35(7):2445-8. PubMed ID: 14611982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abbreviated mycophenolic acid AUC from C0, C1, C2, and C4 is preferable in children after renal transplantation on mycophenolate mofetil and tacrolimus therapy.
    Filler G
    Transpl Int; 2004 Mar; 17(3):120-5. PubMed ID: 14749919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronopharmacokinetics of tacrolimus in kidney transplant recipients: occurrence of acute rejection.
    Tada H; Satoh S; Iinuma M; Shimoda N; Murakami M; Hayase Y; Kato T; Suzuki T
    J Clin Pharmacol; 2003 Aug; 43(8):859-65. PubMed ID: 12953343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
    Marquet P; Albano L; Woillard JB; Rostaing L; Kamar N; Sakarovitch C; Gatault P; Buchler M; Charpentier B; Thervet E; Cassuto E
    Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of tacrolimus (FK 506) in children and adolescents with renal transplants.
    Filler G; Grygas R; Mai I; Stolpe HJ; Greiner C; Bauer S; Ehrich JH
    Nephrol Dial Transplant; 1997 Aug; 12(8):1668-71. PubMed ID: 9269646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
    Pawinski T; Luszczynska P; Durlik M; Majchrzak J; Baczkowska T; Chrzanowska M; Sobiak J; Glyda M; Kuriata-Kordek M; Kamińska D; Krajewska M; Klinger M
    Ther Drug Monit; 2013 Dec; 35(6):760-9. PubMed ID: 24192641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the pharmacokinetics of tacrolimus and microemulsified cyclosporin in paediatric renal transplant recipients.
    Renton KW; Crocker JF; McLellan H; Acott PD
    Eur J Clin Pharmacol; 2004 Aug; 60(6):421-6. PubMed ID: 15232662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abbreviated tacrolimus area-under-the-curve monitoring for renal transplant recipients.
    Wong KM; Shek CC; Chau KF; Li CS
    Am J Kidney Dis; 2000 Apr; 35(4):660-6. PubMed ID: 10739787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapy.
    Nakamura Y; Takeuchi H; Okuyama K; Akashi T; Jojima Y; Konno O; Akashi I; Hama K; Iwahori T; Ashizawa T; Hirano T; Oka K; Matsuno N; Nagao T
    Transplant Proc; 2005 May; 37(4):1725-7. PubMed ID: 15919445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flexible limited sampling model for monitoring tacrolimus in stable patients having undergone liver transplantation with samples 4 to 6 hours after dosing is superior to trough concentration.
    Langers P; Press RR; den Hartigh J; Cremers SC; Baranski AG; Lamers CB; Hommes DW; van Hoek B
    Ther Drug Monit; 2008 Aug; 30(4):456-61. PubMed ID: 18641539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Limited Sampling Strategies for the Estimation of Tacrolimus Area Under the Curve in Adult Kidney Transplant Recipients According to the Posttransplantation Time.
    Aouam K; Chadli Z; Hammouda M; Fredj NB; Aloui S; May ME; Boughattas N; Skhiri H; Chaabane A
    Ther Drug Monit; 2015 Aug; 37(4):524-30. PubMed ID: 25627405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of age, ethnicity, and glucocorticoid use on tacrolimus pharmacokinetics in pediatric renal transplant patients.
    Kim JS; Aviles DH; Silverstein DM; Leblanc PL; Matti Vehaskari V
    Pediatr Transplant; 2005 Apr; 9(2):162-9. PubMed ID: 15787787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients.
    Scholten EM; Cremers SC; Schoemaker RC; Rowshani AT; van Kan EJ; den Hartigh J; Paul LC; de Fijter JW
    Kidney Int; 2005 Jun; 67(6):2440-7. PubMed ID: 15882290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of limited sampling strategies for tacrolimus and mycophenolate in steroid-free renal transplant regimens.
    Poulin E; Greanya ED; Partovi N; Shapiro RJ; Al-Khatib M; Ensom MH
    Ther Drug Monit; 2011 Feb; 33(1):50-5. PubMed ID: 21157401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.